Autophagy contributes to gefitinib-induced glioma cell growth inhibition

Experimental Cell Research

Volumn 327, Issue 1, 2014, Pages 102-112

  Chang, Cheng Yi ^a,b   Kuan, Yu Hsiang ^c,d   Ou, Yen Chuan ^e   Li, Jian Ri ^e   Wu, Chih Cheng ^e,f   Pan, Pin Ho ^g   Chen, Wen Ying ^h   Huang, Hsuan Yi ^a   Chen, Chun Jung ^e,h,i,j  

^a FENG YUAN HOSPITAL   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f PROVIDENCE UNIVERSITY   (Taiwan)

^g TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^h NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

ⁱ TUNGHAI UNIVERSITY   (Taiwan)

^j HUNGKUANG UNIVERSITY   (Taiwan)

more..

Author keywords

AMPK; Autophagy; EGFR; Gefitinib; Glioma

Indexed keywords

3 METHYLADENOSINE; ADENOSINE DERIVATIVE; BECLIN 1; CHLOROQUINE; DANSYLCADAVERINE; GEFITINIB; GREEN FLUORESCENT PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER KINASE B1; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3 II; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN P62; SMALL INTERFERING RNA; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANCER GROWTH; CANCER MODEL; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; GENE DISRUPTION; GENE SILENCING; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; GLIOMA CELL LINE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; STAINING; TUMOR XENOGRAFT;

AMPK; AUTOPHAGY; EGFR; GEFITINIB; GLIOMA;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; GLIOMA; GROWTH INHIBITORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84906938092     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.05.011     Document Type: Article

References (46)

1. Bai L., Wang S. Targeting apoptosis pathways for new cancer therapeutics. Annu. Rev. Med. 2014, 65:139-155.
2. Byun S., Lee S.Y., Lee J., Jeong C.H., Farrand L., Lim S., Reddy K., Kim J.Y., Lee M.H., Lee H.J., Bode A.M., Lee K.W., Dong Z. USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clin. Cancer Res. 2013, 19:3894-3904.
3. Cemeus C., Zhao T.T., Barrett G.M., Lorimer I.A., Dimitroulakos J. Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status. J. Neurooncol. 2008, 90:9-17.
4. Chang C.Y., Shen C.C., Su H.L., Chen C.J. Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation. J. Neurooncol. 2011, 105:507-522.
5. Chao A.C., Hsu Y.L., Liu C.K., Kuo P.L. α-Mangostin, a dietary xanthone, induces autophagic cell death by activating the AMP-activated protein kinase pathway in glioblastoma cells. J. Agric. Food Chem. 2011, 59:2086-2096.
6. Cheng Y., Zhang Y., Zhang L., Ren X., Huber-Keener K.J., Liu X., Zhou L., Liao J., Keihack H., Yan L., Rubin E., Yang J.M. MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Mol. Cancer Ther 2012, 11:154-164.
7. Codogno P., Meijer A.J. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005, 12:1509-1518.
8. Dragowska W.H., Weppler S.A., Wang J.C., Wong L.Y., Kapanen A.I., Rawji J.S., Warburton C., Qadir M.A., Donohue E., Roberge M., Gorski S.M., Gelmon K.A., Bally M.B. Induction of autophagy is an early response to gefitinib and potential therapeutic target in breast cancer. PLoS One 2013, 8:e76503.
9. Egan D.F., Shackelford D.B., Mihaylova M.M., Gelino S.R., Kohnz R.A., Mair W., Vasquez D.S., Joshi A., Gwinn D.M., Taylor R., Asara J.M., Fitzpatrick J., Dillin A., Viollet B., Kundu M., Hansen M., Shaw R.J. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331:456-461.
10. Eimer S., Belaud-Rotureau M.A., Airiau K., Jeanneteau M., Laharanne E., Véron N., Vital A., Loiseau H., Merlio J.P., Belloc F. Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death. Cancer Biol. Ther. 2011, 11:1017-1027.
11. Fu J., Shao C.J., Chen F.R., Ng H.K., Chen Z.P. Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. NeuroOncology 2010, 12:328-340.
12. Godlewski J., Nowicki M.O., Bronisz A., Nuovo G., Palatini J., De Lay M., Van Brocklyn J., Ostrowski M.C., Chiocca E.A., Lawler S.E. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell. 2010, 37:620-632.
13. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
14. Han W., Pan H., Chen Y., Sun J., Wang Y., Li J., Ge W., Feng L., Lin X., Wang X., Wang X., Jin H. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One 2011, 6:e18691.
15. Hegi M.E., Diserens A.C., Bady P., Kamoshima Y., Kouwenhoven M.C.M., Delorenzi M., Lambiv W.L., Hamou M.F., Matter M.S., Koch A., Heppner F.L., Yonekawa Y., Merlo A., Frei K., Mariani L., Hofer S. Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib - a phase II trial. Mol. Cancer Ther 2010, 10:1102-1112.
16. Huang X., Bai H.M., Chen L., Li B., Lu Y.C. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J. Clin. Neurosci. 2010, 17:1515-1519.
17. + glioblastoma xenograft. Mol. Cancer Ther 2009, 8:1751-1760.
18. Lee D.H., Lee T.H., Jung C.H., Kim Y.H. Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells. Cell. Signal. 2012, 24:2216-2225.
19. Lee J.W., Park S., Takahashi Y., Wang H.G. The association of AMPK with ULK1 regulates autophagy. PLoS One 2010, 5:e15394.
20. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
21. Li J.R., Cheng C.L., Yang C.R., Ou Y.C., Wu M.J., Ko J.L. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux. Toxicol. Lett. 2013, 267-276.
22. Li Y.Y., Lam S.K., Mak J.C., Zheng C.Y., Ho J.C. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer. Lung Cancer 2013, 81:354-361.
23. Lin C.J., Lee C.C., Shih Y.L., Lin C.H., Wang S.H., Chen T.H., Shih C.M. Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS One 2012, 7:e38706.
24. Liu W.M., Huang P., Kar N., Burgett M., Muller-Greven G., Nowacki A.S., Distelhorst C.W., Lathia J.D., Rich J.N., Kappes J.C., Gladson C.L. Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy. PLoS One 2013, 8:e70804.
25. Liu W.T., Lin C.H., Hsiao M., Gean P.W. Minocycline inhibits the growth of glioma by inducing autophagy. Autophagy 2011, 7:166-175.
26. Mellinghoff I.K., Wang M.Y., Vivanco I., Haas-Kogan D.A., Zhu S., Dia E.Q., Lu K.V., Yoshimoto K., Huang J.H., Chute D.J., Riggs B.L., Horvath S., Liau L.M., Cavenee W.K., Rao P.N., Beroukhim R., Peck T.C., Lee J.C., Sellers W.R., Stokoe D., Prados M., Cloughesy T.F., Sawyers C.L., Mischel P.S. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N. Engl. J. Med. 2005, 353:2012-2024.
27. Miracco C., Cosci E., Oliveri G., Luzi P., Pacenti L., Monciatti I., Mannucci S., De Nisi M.C., Toscano M., Malagnino V., Falzarano S.M., Pirtoli L., Tosi P. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int. J. Oncol. 2007, 30:429-436.
28. Nagane M., Huang H.J., Cavenee W.K. Advances in the molecular genetics of gliomas. Curr. Opin. Oncol. 1997, 9:215-222.
29. Nishikawa R., Ji X.D., Harmon R.C., Lazar C.S., Gill G.N., Cavenee W.K., Huang H.J. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Nat. Acad. Sci. U.S.A. 1994, 91:7727-7731.
30. Pirtoli L., Cevenini G., Tini P., Vannini M., Oliveri G., Marsili S., Mourmouras V., Rubino G., Miracco C. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 2009, 5:930-936.
31. Premkumar D.R., Arnold B., Pollack I.F. Cooperative inhibitory effect of ZD1839 (Iressa) in combination with 17-AAG on glioma cell growth. Mol. Carcinog. 2006, 45:288-301.
32. Rich J.N., Reardon D.A., Peery T., Dowell J.M., Quinn J.A., Penne K.L., Wikstrand C.J., Van Duyn L.B., Dancey J.E., McLendon R.E., Kao J.C., Stenzel T.T., Ahmed Rasheed B.K., Tourt-Uhlig S.E., Herndon J.E., Vredenburgh J.J., Sampson J.H., Friedman A.H., Bigner D.D., Friedman H.S. Phase II trial of gefitinib in recurrent glioblastoma. J. Clin. Oncol. 2004, 22:133-142.
33. Rubenstein M., Shaw M., Mirochnik Y., Slobodskoy L., Glick R., Lichtor T., Chou P., Guinan P. In vivo establishment of T98G human glioblastoma. Methods Find. Exp. Clin. Pharmacol. 1999, 21:391-393.
34. Russell R.C., Tian Y., Yuan H., Park H.W., Chang Y.Y., Kim J., Kim H., Neufeld T.P., Dillin A., Guan K.L. ULK1 induces autophagy by phosphorylating Beclin 1 and activating VPS34 lipid kinase. Nat. Cell Biol. 2013, 15:741-750.
35. Shen J., Zheng H., Ruan J., Fang W., Li A., Tian G., Niu X., Luo S., Zhao P. Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma. Br. J. Cancer 2013, 109:164-171.
36. Shin S.Y., Lee K.S., Choi Y.K., Lim H.J., Lee H.G., Lim Y., Lee Y.H. The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis 2013, 34:2080-2089.
37. Soni D., King J.A., Kaye A.H., Hovens C.M. Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathway converge. J. Clin. Neurosci. 2005, 12:1-5.
38. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 2007, 100:328-341.
39. Wang S.G., Huang M.H., Li J.H., Lai F.I., Lee H.M., Hsu Y.N. Punicalagin induces apoptotic and autophagic cell death in human U87MG glioma cells. Acta Pharmacol. Sin. 2013, 34:1411-1419.
40. Wang Y.C., Kulp S.K., Wang D., Yang C.C., Sargeant A.M., Hung J.H., Kashida Y., Yamaguchi M., Chang G.D., Chen C.S. Targeting endoplasmic reticulum stress and Akt with OSU-03012 and gefitinib or erlotinib to overcome resistance to epidermal growth factor receptor inhibitors. Cancer Res. 2008, 68:2820-2830.
41. Wong A.J., Ruppert J.M., Bigner S.H., Grzeschik C.H., Humphrey P.A., Bigner D.S., Vogelstein B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Nat. Acad. Sci. U.S.A. 1992, 89:2965-2969.
42. Yamaguchi H., Hsu J.L., Chen C.T., Wang Y.N., Hsu M.C., Chang S.S., Du Y., Ko H.W., Herbst R., Hung M.C. Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells. Clin. Cancer Res. 2013, 19:845-854.
43. Yang Z.J., Chee C.E., Huang S., Sinicrope F.A. The role of autophagy in cancer: therapeutic implications. Mol. Cancer Ther. 2011, 10:1533-1541.
44. Yu H.C., Lin C.S., Tai W.T., Liu C.Y., Shiau C.W., Chen K.F. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J. Biol. Chem. 2013, 288:18249-18259.
45. Zhang R., Banik N.L., Ray S.K. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-κB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Neurochem. Res. 2007, 32:2194-2202.
46. Zhang W., Wang Z., Shu F., Jin Y., Liu H., Wang Q., Yang Y. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J. Biol. Chem. 2010, 285:40461-40471.